Stockscreener 앱 받기
84.16
3.14%
-2.73
시장 영업 전:
85.26
1.10
+1.31%
Nektar Therapeutics 주식(NKTR)의 최신 뉴스
Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Nektar Therapeutics: This Stock Went Up 10x In The Last Year And It's Still Cheap - Seeking Alpha
NKTR UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - ChartMill
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2026 in Nektar Therapeutics LawsuitNKTR - PR Newswire
NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit - ChartMill
NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Nektar Therapeutics and Encourages Investors to Contact the Firm Before May 5th - Scott Coop
Did Fast Track Rezpegaldesleukin Data and New Hires Just Shift Nektar Therapeutics' (NKTR) Investment Narrative? - simplywall.st
NKTR Investor Alert: Nektar Therapeutics Securities Fraud - GlobeNewswire
NEKTAR THERAPEUTICS CLASS ACTION REMINDER: Bragar Eagel & - GlobeNewswire
NKTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - marketscreener.com
Deadline Soon: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - ChartMill
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
NKTR DEADLINE NOTICE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Nektar Therapeutics ... - Caledonian Record
NKTR DEADLINE NOTICE: ROSEN, A GLOBAL INVESTOR RIGHTS LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action - GlobeNewswire Inc.
Why Nektar Therapeutics Stock Rocked it Today - MSN
A Look At Nektar Therapeutics (NKTR) Valuation After New REZOLVE AA Data Funding And Phase 3 Plans - simplywall.st
How The Rezpegaldesleukin Story Is Recasting The Narrative For Nektar Therapeutics (NKTR) - Yahoo Finance
Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PR Newswire
Nektar Therapeutics (NKTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
NKTR UPCOMING DEADLINE : The Gross Law Firm Alerts Nektar - GlobeNewswire
NKTR Stock Price, Quote & Chart | NEKTAR THERAPEUTICS (NASDAQ:NKTR) - ChartMill
Nektar Therapeutics adds to its 129% two-month run with alopecia news - MSN
Nektar Therapeutics (NKTR) price target increased by 12.59% to 147.14 - MSN
Pomerantz Law Firm Announces the Filing of a Class Action Against Nektar Therapeutics and Certain OfficersNKTR - PR Newswire
NKTR Investor Alert: Nektar Therapeutics Securities Fraud Lawsui - GuruFocus
NKTR DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to ... - Caledonian Record
NKTR Investors Have Opportunity to Lead Nektar Therapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 - Morningstar
NEKTAR THERAPEUTICS (NKTR) SHAREHOLDER ALERTBernstein - GlobeNewswire
NKTR Investor Alert: Nektar Therapeutics Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Allegedly Misrepresenting Trial Data Integrity: SueWallSt - Morningstar
Nektar Therapeutics (NKTR) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
United StatesGoodwin Guides Nektar Therapeutics On Its $373.8 Million Underwritten Public Offering, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares - Mondaq
NEKTAR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class ActionNKTR - TMX Newsfile
MSN - MSN
SHAREHOLDER ALERT Securities Class Action Filed Against Nektar Therapeutics (NKTR) - TMX Newsfile
Moody Aldrich Partners LLC Decreases Stock Position in Nektar Therapeutics $NKTR - MarketBeat
Nektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets - BioSpace
Nektar to Announce Financial Results for the First Quarter on Th - GuruFocus
Why Nektar Therapeutics (NKTR) Is Down 8.6% After Raising Capital And Reporting New Alopecia Data - Sahm
ROSEN, LEADING GLOBAL COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action- NKTR - TMX Newsfile
Nektar sets May 7 earnings release, webcast starts 5 p.m. ET - Stock Titan
Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm - Morningstar
Portnoy Law Firm Announces Class Action on Behalf of Nektar Therapeutics, Inc. Investors - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Nektar posts 52-week data from mid-stage trial for hair loss therapy - MSN
Nektar Therapeutics prices $400M stock offering - MSN
Why Nektar Therapeutics Shares Are Sinking Today - TipRanks
NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
NKTR Deadline: NKTR Investors Have Opportunity to Lead Nektar Th - GuruFocus
0.14%
0.48%
자본화:
|
볼륨(24시간):